Q THERAPEUTICS
Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson’s disease, as well as for Alzheimer’s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Therapeutics is headquartered in Salt Lake City, Utah.
Q THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2004-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.qthera.com
Total Employee:
1+
Status:
Active
Contact:
801-582-5400
Email Addresses:
[email protected]
Total Funding:
24.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail JsDelivr Microsoft Azure DNS
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-11-28 | Degania Medical | Degania Medical acquired by Q Therapeutics | N/A |
Investors List
University of Utah Endowment
University of Utah Endowment investment in Venture Round - Q Therapeutics
EPIC Ventures
EPIC Ventures investment in Venture Round - Q Therapeutics
Salt Lake Life Science Angels
Salt Lake Life Science Angels investment in Venture Round - Q Therapeutics
Q management
Q management investment in Venture Round - Q Therapeutics
Toucan Capital
Toucan Capital investment in Venture Round - Q Therapeutics
vSpring Capital
vSpring Capital investment in Venture Round - Q Therapeutics
Official Site Inspections
http://www.qthera.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Q Therapeutics"
Home | qthera
Q Therapeutics has adopted a unique approach to developing human cell-based therapies for debilitating – and currently incurable – diseases of the brain and spinal cord (the central …See details»
About - qthera
Dr. Parks brings to Q Therapeutics more than 30 years experience in life science research and its translation into therapeutic products. As a faculty member in the Department of Neurobiology …See details»
Q Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 801-582-5400 Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment …See details»
Q Therapeutics Company Profile 2024: Valuation, Funding
Q Therapeutics General Information Description. Developer of novel stem cell therapy intended to treat debilitating CNS disease and injury. The company's cell therapies replace the insulating …See details»
Investors | qthera
Q Therapeutics - LinkedIn
Q Therapeutics | 440 followers on LinkedIn. Q has developed a human cell based therapeutic product to treat degenerative disorders of the brain and spinal cord. | Q Therapeutics is a …See details»
Q Therapeutics - Overview, News & Similar companies - ZoomInfo
Www.qthera.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. InVivo Therapeutics Announces Joint Research Collaboration w... Oct 2, 2018. …See details»
qthera.com - Home | qthera - Qthera - Sur.ly
Qthera.com most likely does not offer any adult content. Popular pages. Home | qthera Q-Cells® – our first cellular therapeutic candidate – are human glial progenitor cells that give rise to two …See details»
Goodwin biotech partners with Q Thera in ALS treatment project.
Jul 13, 2015 Goodwin Biotechnology is a biological contract development and manufacturing organization (CDMO) that offers cell line development, exploratory proof of concept projects, …See details»
Quethera - Crunchbase Company Profile & Funding
Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. Our initial focus is on developing therapies to reduce progressive visual …See details»
Pipeline - qthera
Q Therapeutics has a deep pipeline, with significant market potential backed by a strong intellectual property position. Q Therapeutics is actively preparing for first-in-human clinical …See details»
FDA Allows Q-Cells (R) for First-In-Human Transverse Myelitis Trial
Jul 25, 2017 Q Therapeutics, Inc., developer of clinical-stage cell therapies for central nervous system disease and injury, announced U.S. Food and Drug Administration allowance of its …See details»
QUALTHERA
At Qualthera, we are dedicated to providing innovative, custom medication solutions for both healthcare providers and patients. Our mission is to deliver quality therapy for life, ensuring …See details»
Quethera - Contacts, Employees, Board Members, Advisors & Alumni
Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases.See details»
Therapeutic Focus | qthera
Our initial targets are orphan diseases, such as transverse myelitis and ALS, which benefit from an accelerated FDA approval process and market exclusivity.See details»
Quthero.com
In wounded skin, Q-peptide treatment accelerates cell migration and leads to a unique profile of cytokine secretion, enabling faster healing and deposition of new collagen.Q-peptide treatment …See details»
Quethera Company Profile 2024: Valuation, Investors ... - PitchBook
Quethera General Information Description. Developer of gene therapy technologies designed to improve the treatment of common blinding eye diseases. The company's technology focuses …See details»
Technology - qthera
The most common types of glial cells in the brain are: Astrocytes – Specialized cells that protect neurons by producing growth factors, removing toxins, protecting against damage, modulating …See details»
qthera.net
Qthera.netSee details»
News - qthera
Aug 21, 2014 Reversing Paralysis: Stem cell therapy aims to repair spinal cords afflicted by rare disorder. Oct 8, 2018, 8:00 AM EDT InVivo Therapeutics Announces Joint Research …See details»